Skip to main content

  • Impact of left ventricular ejection fraction on 10-year mortality in the SYNTAX trial

    • Posted: 01/03/2024
    • Author:

      Shinichiro Masuda, Patrick W. Serruys, Kai Ninomiya, Shigetaka Kageyama, Kotoku Nozomi, Chao Gao, Michael J. Mack, David R. Holmes, Marie-Claude Morice, Daniel J.F.M. Thuijs, Milan Milojevic, Piroze M. Davierwala, Scot Garg and Yoshinobu Onuma

    • CRM2024

    Abstract

    Backgrounds

    The impact of reduced left ventricular ejection fraction (LVEF) on very long-term prognosis following percutaneous coronary intervention (PCI) or coronary artery bypass graft (CABG) has been debated. The aim of this study was to investigate the impact of LVEF at baseline on 10-year mortality in the SYNTAX trial.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details